What's in Trieu, Nguyen Thi, M.D.'s pipeline?

Trieu, Nguyen Thi, M.D. has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Trieu, Nguyen Thi, M.D.'s portfolio?

Top competitors by shared drug class: Bayer, University of British Columbia, Pfizer, ADvantage Therapeutics, Abbott.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/trieu-nguyen-thi-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Trieu, Nguyen Thi, M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trieu, Nguyen Thi, M.D. pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
SB-UF	SB-UF	marketed			Other
Ahah Drug	Ahah Drug	marketed
ESTROGEN HERBALS 21	ESTROGEN HERBALS 21	marketed
FPT-20	FPT-20	marketed	SGLT2 inhibitor	SGLT2	Diabetes
Dydrogesterone M ( case 2 )	Dydrogesterone M ( case 2 )	marketed	Progestin	Progesterone receptor	Obstetrics/Gynecology
Dydrogesterone M ( case 1 )	Dydrogesterone M ( case 1 )	marketed	Progestin	Progesterone receptor	Obstetrics/Gynecology
ESTROGEN HERBALS 28	ESTROGEN HERBALS 28	marketed			Women's Health / Endocrinology

Therapeutic area mix

Obstetrics/Gynecology · 2
Diabetes · 1
Other · 1
Women's Health / Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 2 shared drug classes
University of British Columbia · 2 shared drug classes
Pfizer · 2 shared drug classes
ADvantage Therapeutics · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Trieu, Nguyen Thi, M.D.:

Cite this brief

Drug Landscape (2026). Trieu, Nguyen Thi, M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/trieu-nguyen-thi-m-d. Accessed 2026-05-17.